神州细胞集团公司 funding history / development milestones

IPO上市，

2020.06.22，上交所

Note: collected from public online reports, for reference only.

Talent Demand Trend Analysis More

抗体

生物制药

免疫学

疫苗临床试验

病毒疫苗

快速诊断

ELISA

药代试验

临床医学

生物制品

疫苗技术

医药

酶联免疫

保护试剂

蛋白质药物

People who follow 神州细胞集团公司 also follow

神州细胞集团公司 Competitors (Similar Companies)

Follow in Bulk Copy Company Names

China Resources Pharmaceutical Commercial Group Co., Ltd.

“Large-scale pharmaceutical distribution enterprise”

Johnson & Johnson (China) Co., Ltd.

“Caring for the world, one person at a time”

MSD (China) Investment Co., Ltd.

“We focus on scientific innovation, exploring, developing, and providin”

中国医学科学院阜外医院

临床研究临床试验冠脉介入临床医学

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

“An innovative biopharmaceutical enterprise focusing on antibody drugs”

北京鼎持生物技术有限公司

“培养基及疫苗生产技术研发商”

Beijing Kawin Technology Co., Ltd.

“Striving to become a pioneer in the field of viral and immune diseases”

Beijing Sinovac Biotech Co., Ltd.

“Engaged in the research and development as well as technical services ”

ACROBiosystems Co., Ltd. (Beijing)

“Brand of protein reagents for target drug development”

Xinjiang Joinworld Co., Ltd.

“High-purity aluminum production base and enterprise for R&D and produc”

Huadong Medicine Co., Ltd.

“Mainly engaged in the production and sales of antibiotics, traditional”

Sinocell Engineering Co., Ltd.

“An enterprise engaged in R&D and industrialization of recombinant prot”

中 中文版 View this page in Chinese ›